```html

Sexually Transmitted Infection (Chlamydia): A Comprehensive Medical Guide

Overview

Chlamydia is a bacterial sexually transmitted infection (STI) caused by Chlamydia trachomatis. It is the most commonly reported bacterial STI in the United States and many other countries worldwide.

• Prevalence: In 2022 the CDC recorded ~1.8 million cases in the U.S., a 12 % increase from the prior year. Globally, the World Health Organization estimates >127 million new cases annually.
• Who it affects: People of any gender, age, or sexual orientation can acquire chlamydia, but adolescents and young adults (15‑24 years) account for roughly 70 % of U.S. cases.
• Transmission: The bacteria spread through vaginal, anal, or oral sex with an infected partner. Mother‑to‑child transmission can occur during childbirth, leading to conjunctivitis or pneumonia in newborns.

Symptoms

Up to 75 % of people with chlamydia are asymptomatic, which is why routine screening is essential. When symptoms do appear, they vary by sex and anatomic site of infection.

Women

• Abnormal vaginal discharge (yellow‑white, watery)
• Burning sensation during urination
• Lower abdominal or pelvic pain
• Bleeding between periods or after intercourse
• Rectal pain, discharge, or bleeding (if infection is rectal)
• Throat soreness (if infected orally)

Men

• Discharge from the penis (white, cloudy, or watery)
• Burning or itching during urination
• Testicular pain or swelling
• Rectal pain, discharge, or bleeding (if infection is rectal)
• Sore throat (if infected orally)

People Who Have Sex with Men (MSM)

• Rectal pain, discharge, or bleeding
• Anal itching or soreness
• Urethral symptoms similar to heterosexual men

Infants (Neonatal Chlamydia)

• Conjunctivitis (red, watery eyes) within the first 2 weeks of life
• Pneumonia presenting as coughing or rapid breathing

Causes and Risk Factors

Chlamydia is caused by the obligate intracellular bacterium Chlamydia trachomatis. The infection does not result from poor hygiene; it is strictly transmitted through sexual contact or perinatal exposure.

Primary Causes

• Unprotected vaginal, anal, or oral sex with an infected partner.
• Sex with multiple partners, especially when condoms are not used consistently.
• Previous or current STI (co‑infection is common).

Risk Factors

• Age: 15‑24 years old.
• Gender: Women are more likely to develop complications, though men transmit the infection at similar rates.
• Sexual behavior: Having more than one partner, inconsistent condom use, or a history of STIs.
• Socio‑economic factors: Limited access to healthcare and screening programs.
• Pregnancy: Infected pregnant women can transmit the infection to the baby.

Diagnosis

Because many infections are silent, laboratory testing is the gold standard.

Recommended Screening

• Annual screening for sexually active women ≤25 years, pregnant women, and men who have sex with men (MSM).
• More frequent testing (every 3–6 months) for individuals with new or multiple partners.

Laboratory Tests

• Nucleic Acid Amplification Test (NAAT): The most sensitive test; can be performed on urine, vaginal swabs, or rectal/oral specimens.
• Culture: Rarely used today due to lower sensitivity but may be needed for antibiotic‑resistance monitoring.
• Direct Fluorescent Antibody (DFA) or Enzyme Immunoassay (EIA): Older methods, less common.

Physical Examination

A clinician may inspect the genital, anal, and oral areas for discharge, lesions, or inflammation, but a normal exam does not rule out infection.

Treatment Options

Chlamydia is highly curable with antibiotics. Prompt treatment prevents complications and halts transmission.

First‑Line Antibiotics

• Doxycycline 100 mg orally twice daily for 7 days – most widely recommended (CDC 2024).
• Azig (Azithromycin) 1 g orally in a single dose – useful for patients who cannot take a 7‑day regimen (e.g., pregnant women).

Pregnancy Considerations

• Azig 1 g single dose or Doxycycline alternative (Amoxicillin 500 mg TID for 7 days) if azithromycin contraindicated.

Partner Management

• All sexual partners within the past 60 days should be notified, tested, and treated (“expedited partner therapy” is legal in many U.S. states).
• Abstain from sexual activity for 7 days after completing antibiotics and until all partners are cleared.

Follow‑Up

• Retesting (test‑of‑cure) is not routinely required for uncomplicated infections but is advised 3 months after treatment for pregnant women, HIV‑positive patients, or those with reinfection risk.

Living with Sexually Transmitted Infection (Chlamydia)

Even after successful treatment, managing the emotional and practical aspects of an STI diagnosis is important.

Practical Tips

• Complete the full course of antibiotics even if symptoms resolve.
• Inform current and recent partners promptly; use partner‑notification services if needed.
• Use condoms or dental dams consistently to reduce re‑exposure.
• Schedule regular STI screens—once a year is a good baseline; more often if you have multiple partners.
• Maintain a symptom diary for a week after treatment; alert your provider if symptoms persist.

Emotional Support

• STI stigma is common; consider counseling or support groups (e.g., Planned Parenthood, local health department).
• Educate yourself—knowledge reduces anxiety and promotes safer sexual choices.

Prevention

Prevention strategies focus on reducing exposure and encouraging early detection.

Barrier Protection

• Correct and consistent use of latex or polyurethane condoms for vaginal, anal, and oral sex.
• Dental dams for oral‑genital contact.

Vaccination

Currently, no vaccine exists for chlamydia, but research is ongoing (NIH, 2023).

Regular Screening

• Annual testing for sexually active women ≤25 years and for MSM.
• Pregnant women should be screened at the first prenatal visit.

Sexual Health Education

• Open communication with partners about STI status and testing history.
• Limiting the number of concurrent sexual partners.
• Avoiding alcohol or drugs that may impair judgment during sexual encounters.

Complications

If untreated, chlamydia can cause serious, sometimes irreversible damage.

Women

• Pelvic Inflammatory Disease (PID): Up to 30 % develop PID, leading to chronic pelvic pain, infertility, and ectopic pregnancy.
• Fitz-Hugh‑Curtis syndrome: Perihepatic inflammation causing right‑upper‑quadrant pain.

Men

• Epididymitis: Inflammation of the epididymis can cause pain, swelling, and rarely infertility.
• Prostatitis: Chronic prostatitis may result in urinary symptoms.

Both Sexes

• Increased risk of acquiring or transmitting HIV.
• Reactive arthritis (formerly Reiter’s syndrome) – a triad of arthritis, conjunctivitis, and urethritis.

When to Seek Emergency Care

---

References: Centers for Disease Control and Prevention (CDC). Sexually Transmitted Diseases Treatment Guidelines, 2024; World Health Organization (WHO). Global STI Report 2023; Mayo Clinic. Chlamydia infection; Cleveland Clinic. Chlamydia: Symptoms and treatment; NIH. Chlamydia trachomatis – Research Updates, 2023.

```